387938152	387938152	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
75793530	75793530	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
530535	530535	CD	B-NP	O
|	|	CC	I-NP	O
10/19/2002	10/19/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEMOPTYSIS	HEMOPTYSIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/23/2002	2/23/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/19/2002	3/19/2002	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Briefly	Briefly	NNP	B-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Coxum	Coxum	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
on	on	IN	B-PP	O
3/1	3/1	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
massive	massive	JJ	B-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
pink	pink	JJ	I-NP	O
sputum	sputum	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Cox	Cox	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
possible	possible	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
massive	massive	JJ	B-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
BUOHC	BUOHC	NN	B-NP	B-protein
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
anesthesia	anesthesia	NN	B-NP	O
and	and	CC	O	O
intubated	intubate	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
double	double	JJ	I-NP	O
lumen	lumen	NN	I-NP	O
ETT	ETT	NN	I-NP	O
for	for	IN	B-PP	O
airway	airway	NN	B-NP	O
protection	protection	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
O.R.	O.R.	NNP	I-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
endobronchial	endobronchial	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
bifurcation	bifurcation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
lobes	lobe	NNS	I-NP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
which	which	WDT	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
revealed	reveal	VBD	B-VP	O
clot	clot	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
endobronchial	endobronchial	JJ	I-NP	O
blocker	blocker	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hemoptysis	hemoptysis	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/15	3/15	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
bronchoscopic	bronchoscopic	JJ	I-NP	O
Wang	Wang	NNP	I-NP	O
needle	needle	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
nondiagnostic	nondiagnostic	JJ	B-ADJP	O
but	but	CC	O	O
showed	show	VBD	B-VP	O
cells	cell	NNS	B-NP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
non	non	JJ	B-NP	O
small	small	JJ	I-NP	O
cell	cell	NN	I-NP	O
lung	lung	NN	I-NP	O
cell	cell	NN	I-NP	O
cancer	cancer	NN	I-NP	O
versus	versus	IN	B-PP	O
squamous	squamous	JJ	B-NP	O
metaplasia	metaplasia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
easily	easily	RB	I-VP	O
extubated	extubate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
3/15	3/15	CD	B-NP	O
without	without	IN	B-PP	O
event	event	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
alcohol	alcohol	NN	B-NP	O
,	,	,	O	O
PAF	PAF	NN	B-NP	B-protein
,	,	,	O	O
BPH	BPH	NN	B-NP	O
,	,	,	O	O
glaucoma	glaucoma	NN	B-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
DVTs	DVT	NNS	B-NP	O
,	,	,	O	O
CVA	CVA	NN	B-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
right	right	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
and	and	CC	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
pilonidal	pilonidal	JJ	B-NP	O
cyst	cyst	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
Keflex	Keflex	NNP	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
HOME	HOME	NN	I-NP	O
:	:	:	O	O
Zestril	Zestril	NNP	B-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

MEDS	MEDS	NNP	B-NP	O
ON	ON	NNP	I-NP	O
TRANSFER	TRANSFER	NN	I-NP	O
:	:	:	O	O
Also	Also	RB	B-ADVP	O
include	include	VBP	B-VP	O
Diltiazem	Diltiazem	NNP	B-NP	O
,	,	,	O	O
levo	levo	NN	B-NP	O
.	.	.	O	O

and	and	CC	O	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
,	,	,	O	O
Nitropaste	Nitropaste	NN	B-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
,	,	,	O	O
Heparin	Heparin	NNP	B-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
80	80	CD	B-NP	O
pack	pack	NN	I-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
.	.	.	O	O

Alcohol	Alcohol	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
repeat	repeat	NN	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hemoptysis	hemoptysis	NN	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
body	body	NN	I-NP	O
bone	bone	NN	I-NP	O
scan	scan	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
skeletal	skeletal	JJ	I-NP	O
metastasis	metastasis	NN	I-NP	O
found	find	VBN	B-VP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
on	on	IN	B-PP	O
2/10	2/10	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
consolidation	consolidation	NN	B-NP	O
improved	improve	VBD	B-VP	O
since	since	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hilar	hilar	JJ	I-NP	O
or	or	CC	I-NP	O
mediastinal	mediastinal	JJ	I-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
attenuation	attenuation	NN	I-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
enlargement	enlargement	NN	B-NP	O
within	within	IN	B-PP	O
both	both	DT	B-NP	O
adrenal	adrenal	JJ	I-NP	O
glands	gland	NNS	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
CT.	CT.	NNP	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
calcified	calcify	VBN	B-NP	O
gallstone	gallstone	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
apical	apical	JJ	I-NP	O
adrenal	adrenal	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
needing	need	VBG	B-VP	O
further	further	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
tiny	tiny	JJ	I-NP	O
,	,	,	O	O
hypoattenuating	hypoattenuate	VBG	B-VP	O
liver	liver	NN	B-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
liver	liver	NN	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
metastasis	metastasis	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
finding	finding	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adrenal	adrenal	JJ	I-NP	O
glands	gland	NNS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
without	without	IN	B-PP	O
contrast	contrast	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
completed	complete	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
case	case	NN	I-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Doogan	Doogan	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Amoa	Amoa	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Hartt	Hartt	NNP	I-NP	O
at	at	IN	B-PP	O
length	length	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
possibly	possibly	RB	I-VP	O
be	be	VB	I-VP	O
offered	offer	VBN	I-VP	O
left	left	JJ	B-NP	O
upper	upper	JJ	I-NP	O
lobectomy	lobectomy	NN	I-NP	O
for	for	IN	B-PP	O
both	both	CC	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
and	and	CC	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
purposes	purpose	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
biopsy	biopsy	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
visible	visible	JJ	I-NP	O
adrenal	adrenal	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
potential	potential	JJ	B-NP	O
medical	medical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
would	would	MD	B-VP	O
include	include	VB	I-VP	O
chemotherapy	chemotherapy	NN	B-NP	O
and	and	CC	I-NP	O
radiation	radiation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
with	with	IN	B-PP	O
O2	O2	NN	B-NP	O
sats	sat	NNS	I-NP	O
remaining	remain	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
90s	90	NNS	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
one	one	CD	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
develop	develop	VB	I-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
inspiratory	inspiratory	JJ	I-NP	O
stridor	stridor	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
PA	PA	NN	I-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hemoptysis	hemoptysis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
returned	return	VBD	I-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
d.	d.	FW	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Captopril	Captopril	NNP	B-NP	O
and	and	CC	I-NP	O
Lopressor	Lopressor	NNP	I-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
be	be	VB	I-VP	O
stopped	stop	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
levo	levo	NN	B-NP	O
.	.	.	O	O

and	and	CC	O	O
Flagyl	Flagyl	NNP	B-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
week	week	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

PPD	PPD	NN	B-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

BAL	BAL	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Was	Wa	NNS	B-NP	B-protein
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
swallowing	swallow	VBG	I-NP	O
difficulties	difficulty	NNS	I-NP	O
with	with	IN	B-PP	O
possible	possible	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
video	video	NN	I-NP	O
fluoroscopy	fluoroscopy	NN	I-NP	O
study	study	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
penetration	penetration	NN	B-NP	O
and	and	CC	I-NP	O
aspiration	aspiration	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
consistencies	consistency	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
decreased	decrease	VBN	B-NP	O
epiglottic	epiglottic	JJ	I-NP	O
deflection	deflection	NN	I-NP	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
residue	residue	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
piriform	piriform	NN	I-NP	O
sinuses	sinus	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
all	all	DT	B-NP	O
feeds	feed	NNS	I-NP	O
and	and	CC	I-NP	O
pills	pill	NNS	I-NP	O
through	through	IN	B-PP	O
it	it	PRP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
remain	remain	VB	I-VP	O
NPO	NPO	NN	B-NP	B-protein
until	until	IN	B-SBAR	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
video	video	NN	I-NP	O
fluoroscopy	fluoroscopy	NN	I-NP	O
is	be	VBZ	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
thereafter	thereafter	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
required	require	VBD	B-VP	O
high	high	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
notably	notably	RB	B-NP	O
80	80	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
85	85	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
p.m.	p.m.	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
breakthrough	breakthrough	NN	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
bilateral	bilateral	JJ	B-NP	O
ankle	ankle	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
albumin	albumin	NN	I-NP	O
of	of	IN	B-PP	O
3.9	3.9	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
EF	EF	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
cardiovascular	cardiovascular	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
renal	renal	JJ	I-ADJP	O
in	in	IN	B-PP	O
origin	origin	NN	B-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

LENIs	LENI	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
8/20/02	8/20/02	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
with	with	IN	B-PP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Wickett	Wickett	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Alba	Alba	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Artificial	Artificial	JJ	B-NP	O
tears	tear	NNS	I-NP	O
two	two	CD	B-NP	O
drops	drop	NNS	I-NP	O
o.u.	o.u.	RB	B-ADVP	O
t.i.d.	t.i.d.	RB	I-ADVP	O
,	,	,	O	O
Atenolol	Atenolol	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
d.	d.	FW	I-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
d.	d.	FW	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
85	85	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
80	80	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
Nystatin	Nystatin	NN	B-NP	B-protein
swish	swish	VB	B-VP	O
and	and	CC	I-VP	O
swallow	swallow	VB	I-VP	O
,	,	,	O	O
Thiamine	Thiamine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
d.	d.	FW	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
h.s.	h.s.	FW	I-NP	O
,	,	,	O	O
Ambien	Ambien	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
d.	d.	FW	I-NP	O
,	,	,	O	O
and	and	CC	O	O
multivitamin	multivitamin	NN	B-NP	O
12/5	12/5	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
d	d	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
until	until	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
regards	regard	NNS	B-NP	O
to	to	TO	B-PP	O
swallowing	swallow	VBG	B-VP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
ALEJANDRO	ALEJANDRO	NNP	B-NP	O
HEITSCHMIDT	HEITSCHMIDT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WQ37	WQ37	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JOESPH	JOESPH	NNP	B-NP	O
RYBURN	RYBURN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TS67	TS67	NNP	I-NP	O
WH755/761742	WH755/761742	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
69709	69709	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

Z6FYJLTS74	Z6FYJLTS74	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
5/25/02	5/25/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/25/02	5/25/02	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

KORTHAUER	KORTHAUER	NN	B-NP	O
,	,	,	O	O
CLARK	CLARK	NNP	B-NP	O
FELTON	FELTON	NNP	I-NP	O
BRET	BRET	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

JC	JC	NNP	B-NP	O
BURKETTE	BURKETTE	NNP	I-NP	O
,	,	,	O	O
M.D	M.D	NNP	B-NP	O
.	.	.	O	O

